WASHINGTON, Aug. 29, 2023 /PRNewswire/ — This morning, the Centers for Medicare and Medicaid Services (CMS) announced the first 10 Part D drugs to be subject to Medicare price-setting. Sue Peschin, MHS, President and CEO at the Alliance for Aging Research, issued the following statement…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.